Carmen Balaña

Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Jacoline Bromberg

Erasmus University Rotterdam

NETHERLANDS

View details

Elies Fuster-Garcia

Associate Professor (Profesor Titular)

Universitat Politècnica de València

SPAIN

View details

Ainhoa Hernandez

Catalan Institute of Oncology

SPAIN

View details

Giuseppe Minniti

Sapienza University of Rome

ITALY

View details

Anna Esteve

Institut Català d'Oncologia

SPAIN

View details

Pilar Navarro

Cientifico Titular-Head of the " Cancer Molecular Targets" group

SPAIN

View details

Juan M Garcia-Gomez

Profesor Titular de Universidad

Universitat Politècnica de València

SPAIN

View details

Marta Domenech

Institut Català d'Oncologia

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Carmen Balaña

Research Interests

Explore related searches

Contact this professor

Articles (10)

Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker

Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects

Optimal duration of adjuvant temozolomide in glioblastoma: An unsolved and unsolvable problem

Author Correction: EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

Glioblastoma: Relationship between Metabolism and Immunosuppressive Microenvironment

Hypoxia: The Cornerstone of Glioblastoma

Lack of Benefit of Extending Temozolomide Treatment in Patients with High Vascular Glioblastoma with Methylated MGMT

Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase 2 study of the EORTC Brain Tumor Group (EORTC-1320-BTG)

Reply to: Extended adjuvant temozolomide in newly diagnosed glioblastoma: the more, the better?

The need for geriatric scales in glioblastoma

Collaborators (8)

Jacoline Bromberg

Elies Fuster-Garcia

Ainhoa Hernandez

Giuseppe Minniti

Anna Esteve

Pilar Navarro

Juan M Garcia-Gomez

Marta Domenech

Make your next move.